Cardiovascular disease (CVD) refers to a group of disorders that affect the heart and blood vessels. Heart diseases are the leading cause of death in the United States, and it is estimated that a CVD-related fatality happens every 34 seconds.
While CVD medications are available, finding the right dosage and treatment plan can be a time-consuming process for individuals, and most patients will have to take multiple drugs daily for the rest of their lives. For this reason, clinical trials that aim to discover new potential treatments can be vital to improving the lives of those diagnosed with CVD.
For this whitepaper, Antidote analyzed data from over 16,000 CVD patients in our database to learn more about how this diagnosis impacts a person’s life, and how clinical trials can help. We share insights into demographics, racial disparity, prevalence, and more — download it today to see what we’ve learned.
